Literature DB >> 9918085

Screening for chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow.

A Matias1, C Gomes, N Flack, N Montenegro, K H Nicolaides.   

Abstract

OBJECTIVE: To assess the possible role of Doppler ultrasound assessment of ductus venosus blood flow in screening for chromosomal abnormalities at 10-14 weeks of gestation.
METHODS: Ductus venosus flow velocity waveforms were obtained immediately before fetal karyotyping in 486 consecutive singleton pregnancies at 10-14 weeks of gestation. All cases were screened for chromosomal defects by a combination of maternal age and fetal nuchal translucency thickness. The peak systolic and diastolic velocities, the velocity during atrial contraction and the pulsatility index were measured.
RESULTS: There were 63 chromosomal defects (38 cases of trisomy 21, 12 cases of trisomy 18, seven cases of trisomy 13, three cases of Turner's syndrome and three cases of triploidy). In 57 (90.5%) cases there was reverse or absent flow during atrial contraction. Abnormal ductus venosus flow was also observed in 13 (3.1%) of the 423 chromosomally normal fetuses. In the chromosomally abnormal group, compared to the normal group, the median heights of the S and D waves were significantly lower and the pulsatility index was significantly higher. However, multivariate regression analysis demonstrated that only the height of the A wave provided a significant independent contribution in distinguishing between the chromosomally normal and abnormal groups.
CONCLUSION: These preliminary results suggest that assessment of ductus venous blood flow in pregnancies considered to be at high risk for chromosomal defects may result in a major reduction in the need for invasive testing, with only a small decrease in sensitivity.

Entities:  

Mesh:

Year:  1998        PMID: 9918085     DOI: 10.1046/j.1469-0705.1998.12060380.x

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  8 in total

Review 1.  Fetal programming as a predictor of adult health or disease: the need to reevaluate fetal heart function.

Authors:  Joana O Miranda; Carla Ramalho; Tiago Henriques-Coelho; José Carlos Areias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 2.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

3.  Can the ductus venosus doppler predict the hemoglobinopathies?

Authors:  Atilla Karateke; Dilek Benk Silfeler; Arif Güngören; Raziye Keskin Kurt; Ayşe Güler Okyay; Recep Dokuyucu; Turker Ulutas; Burak Un; Hacer Paksoy; Ali Ulvi Hakverdi
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Pregnancy Outcome of Abnormal Nuchal Translucency: A Systematic Review.

Authors:  Nasibeh Roozbeh; Maryam Azizi; Leili Darvish
Journal:  J Clin Diagn Res       Date:  2017-03-01

5.  The assessment of nuchal translucency and serum markers for down syndrome screening with ductus venosus Doppler measurements in the first trimester.

Authors:  Ozlem Ozer; Cenk N Sayın; Füsun G Varol
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-12-01

6.  Employ ductus venous blood flow in the early detection of trisomy 21, trisomy 18, and trisomy 13: A meta-analysis.

Authors:  Yibing Ge; Lili Xia; Yun Wu; Hongbao Cao
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

7.  Efficacy of fetal cardiac axis evaluation in the first trimester as a screening tool for congenital heart defect or aneuploidy.

Authors:  Youn-Joon Jung; Bo-Ra Lee; Gwang Jun Kim
Journal:  Obstet Gynecol Sci       Date:  2020-04-07

8.  Sex differences in fetal Doppler parameters during gestation.

Authors:  Dakshita Jagota; Hannah George; Melissa Walker; Anjana Ravi Chandran; Natasha Milligan; Shiri Shinar; Clare L Whitehead; Sebastian R Hobson; Lena Serghides; W Tony Parks; Ahmet A Baschat; Christopher K Macgowan; John G Sled; John C Kingdom; Lindsay S Cahill
Journal:  Biol Sex Differ       Date:  2021-03-10       Impact factor: 5.027

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.